Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.
Ezgi Deniz BatuSeher ŞenerVeysel CamNuray Aktay AyazSeher SenerPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
The presented systematic literature search revealed that TNF-α inhibitors followed by interferons were the most frequently used biologic drugs in pediatric BD. Both group of biologic treatments appeared to be effective and have an acceptable safety profile in pediatric BD. However, controlled studies are required for analyzing indications for biologic treatments in pediatric BD.